Population genomic screening of all young adults in Australia to detect familial hypercholesterolemia: a cost-effectiveness analysis

被引：0
|
作者：
Ademi, Z. [1 ]
Marquina, C. [1 ]
Lacaze, P. [1 ]
Tiller, J. [1 ]
Riaz, M. [1 ]
Sturm, A. C. [2 ]
Nelson, M. [1 ]
Ference, B. A. [3 ]
Pang, J. [4 ]
Watts, G. F. [4 ]
Nicholls, S. J. [1 ]
Zoungas, S. [1 ]
Liew, D. [1 ]
McNeil, J. [1 ]
机构：
[1] Monash Univ, Melbourne, Vic, Australia
[2] Genom Med Inst, Geisinger, MD USA
[3] Univ Cambridge, Cambridge, England
[4] Univ Western Australia, Perth, WA, Australia
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2727 / 2727
页数：1
相关论文
共 50 条
  • [31] Screening for proteinuria in US adults - A cost-effectiveness analysis
    Boulware, LE
    Jaar, BG
    Tarver-Carr, ME
    Brancati, FL
    Powe, NR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23): : 3101 - 3114
  • [32] Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia
    Barbara de Graaff
    Amanda Neil
    Lei Si
    Kwang Chien Yee
    Kristy Sanderson
    Lyle Gurrin
    Andrew J. Palmer
    Applied Health Economics and Health Policy, 2017, 15 : 521 - 534
  • [33] Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia
    de Graaff, Barbara
    Neil, Amanda
    Si, Lei
    Yee, Kwang Chien
    Sanderson, Kristy
    Gurrin, Lyle
    Palmer, Andrew J.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (04) : 521 - 534
  • [34] COST-EFFECTIVENESS CONSIDERATIONS IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH MEDICATIONS
    GOLDMAN, L
    GOLDMAN, PA
    WILLIAMS, LW
    WEINSTEIN, MC
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (10): : D75 - D79
  • [35] Universal Screening for Familial Hypercholesterolemia in Young Adults: The Young FH Study
    Okazaki, Sachiko
    Takase, Satoru
    Tanaka, Masaki
    Kubota, Midori
    Amiya, Eisuke
    Takanashi, Mikio
    Li, Chengcheng
    Shi, Jingxuan
    Noto, Hiroshi
    Iizuka, Yoko
    Yanagimoto, Shintaro
    Kadowaki, Takashi
    Yamauchi, Toshimasa
    Okazaki, Hiroaki
    CIRCULATION, 2020, 142
  • [36] UPDATED COST EFFECTIVENESS MODEL FOR GENOMIC SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS WITH HIGH LDL CHOLESTEROL LEVELS
    Fishberg, Robert D.
    Rosenberg, Zeil
    Song, Qingxuan
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 50 - 51
  • [37] Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
    Jackson, Candace L.
    Huschka, Todd
    Borah, Bijan
    Agre, Katherine
    Zordok, Magdi
    Farwati, Medhat
    Moriarty, James
    Kullo, Iftikhar J.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 8
  • [38] Optimal screening strategy for familial intracranial aneurysms A cost-effectiveness analysis
    Bor, A. Stijntje E.
    Koffijberg, Hendrik
    Wermer, Marieke J. H.
    Rinkel, Gabriel J. E.
    NEUROLOGY, 2010, 74 (21) : 1671 - 1679
  • [39] Screening for proteinuria in US adults: A cost-effectiveness analysis.
    Boulware, LE
    Jaar, BG
    Tarver-Carr, ME
    Brancati, FL
    Powe, NR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 681A - 681A
  • [40] COST-EFFECTIVENESS OF POPULATION SCREENING FOR HAEMOCHROMATOSIS IN AUSTRALIA: A STATE-TRANSITION MODEL
    de Graaff, B. L.
    Si, L.
    Neil, A.
    Yee, K. C.
    Sanderson, K.
    Gurrin, L. C.
    Palmer, A. J.
    VALUE IN HEALTH, 2016, 19 (07) : A874 - A875
12345